When was EuroscreenFast founded?

EuroscreenFast was founded in 1994.

Where is EuroscreenFast located?

EuroscreenFast is headquartered in Charleroi, Belgium. It is registered at Rīga, Brīvības gatve 235.

Which legal entities is EuroscreenFast associated with?

EuroscreenFast is associated with EUROSCREEN and 1 other.

How many employees does EuroscreenFast have?

As of Jul 01, 2024, the latest employee count at EuroscreenFast is 6.

Is EuroscreenFast a funded company?

EuroscreenFast is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does EuroscreenFast rank among its competitors?

EuroscreenFast ranks 58th amongst 114 active competitors, of which 15 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Metagen Therapeutics, which secured $7.62M in Feb, 2026.

Who are the top competitors of EuroscreenFast?

EuroscreenFast's top competitors include Centivax, Medeloop and Hyku Biosciences. Among them, Metagen Therapeutics secured the most recent funding round in February, 2026.

EuroscreenFast - 2026 Company Profile & Competitors

Company Details

Website: euroscreenfast.com
Social
Registered Address: Rīga, Brīvības gatve 235

Key Metrics

Founded Year

1994

Location

Charleroi, Belgium

Stage

Unfunded

Ranked

58^th among 114 active competitors

Employee Count

6 as on Jul 01, 2024

Similar Companies

Centivax & 129 more

View EuroscreenFast's full profile

EuroscreenFast is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
EUROSCREEN CIN: 40003380763 , Latvia, Active	Feb 20, 1998	$689K (As on Dec 31, 2024)	4 (As on Dec 31, 2023)	-
Epics Therapeutics SA CIN: 0690.759.071 , Belgium, Active	Feb 19, 2018	$14M (As on Dec 31, 2024)	30 (As on Dec 31, 2020)	-

EuroscreenFast has not raised any funding rounds yet.

EuroscreenFast's employee count trend

EuroscreenFast has 6 employees as of Jul 24. Here is EuroscreenFast's employee count trend over the years:

Uncover EuroscreenFast's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of EuroscreenFast include Centivax, Medeloop and Hyku Biosciences. Here is the list of Top 10 competitors of EuroscreenFast, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Centivax 2019, San Francisco (United States), Series A	Provider of drug discovery services	$55M	NFX, Future Ventures & 12 others	55/100
2nd	Medeloop 2021, San Francisco (United States), Series A	CRO focused on drugs discovery services	$23.5M	General Catalyst, Inovia Capital & 8 others	53/100
3rd	Hyku Biosciences 2023, Lexington (United States), Seed	Covalent medicines platform for expanding the boundaries of drug discovery	$62.6M	RA Capital Management, Novartis Venture Fund ... & 4 others	51/100
4th	Pure Biologics 2010, Wroclaw (Poland), Series A	Specialized CRO with expertise in recombinant protein production and purification	$2.6M	-	49/100
5th	Metagen Therapeutics 2020, Tokyo (Japan), Series B	CRO focused on providing microbiome drug discovery and development services	$23.3M	FTI, JIC Venture Growth Investments & 19 others	47/100
6th	Sirion Biotech 2005, Planegg (Germany), Acquired	Provides customised AAV based viral vectors and gene therapy	-	Kfw, HTGF & 4 others	45/100
7th	Plasmid Factory 2000, Bielefeld (Germany), Public	Contract developer and manufacturer of Plasmid DNA	-	ARCHIMED	43/100
8th	Sanyou Biopharmaceuticals 2015, Shanghai (China), Series B	CRO focused on providing cell and molecular biology services for antibody drug discovery	-	LH Ventures, Haier & 3 others	42/100
9th	inbiome 2019, Amsterdam (Netherlands), Funding Raised	CRO focused on developing molecular culture	-	DutchBasecamp, EIC Fund	39/100
10th	Biolexis Therapeutics 2021, Salt Lake City (United States), Series A	CRO focused on drug discovery of small molecule therapeutics	$12.5M	Clarke Capital Partners	38/100
58th	EuroscreenFast 1994, Charleroi (Belgium), Unfunded	CRO focused on assay & cell lines development, deorphanization, and screening services	-	-	20/100